Re-Engineered Stromal Cell-Derived Factor-1α and the Future of Translatable Angiogenic Polypeptide Design

Trends in Cardiovascular Medicine

Volumn 22, Issue 6, 2012, Pages 139-144

  Hiesinger, William ^a   Goldstone, Andrew B ^a   Woo, Y Joseph ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE ESA; RECOMBINANT PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; RECEPTOR BINDING; REVIEW;

ANGIOGENIC PROTEINS; ANIMALS; CHEMOKINE CXCL12; FORECASTING; HUMANS; MICE; PROTEIN ENGINEERING;

EID: 84868284752     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.07.010     Document Type: Review

References (45)

1. Abbott J.D., Huang Y., Liu D., et al. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004, 110:3300-3305.
2. Araszkiewicz A., Grajek S., Lesiak M., et al. Effect of impaired myocardial reperfusion on left ventricular remodeling in patients with anterior wall acute myocardial infarction treated with primary coronary intervention. Am J Cardiol 2006, 98:725-728.
3. Askari A.T., Unzek S., Popovic Z.B., et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue Regeneration in ischaemic cardiomyopathy. Lancet 2003, 362:697-703.
4. Atluri P., Liao G.P., Panlilio C.M., et al. Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy. Ann Thorac Surg 2006, 81:1728-1736.
5. Atluri P., Panlilio C.M., Liao G.P., et al. Transmyocardial revascularization to enhance myocardial vasculogenesis and hemodynamic function. J Thorac Cardiovasc Surg 2008, 135:283-291.
6. Atluri P., Woo Y.J. Pro-angiogenic cytokines as cardiovascular therapeutics: Assessing the potential. BioDrugs 2008, 22:209-222.
7. Balcells E., Powers E.R., Lepper W., et al. Detection of myocardial viability by contrast echocardiography in acute infarction predicts recovery of resting function and contractile reserve. J Am Coll Cardiol 2003, 41:827-833.
8. Baumann L., Prokoph S., Gabriel C., et al. A novel, biased-like SDF-1 derivative acts synergistically with starPEG-based heparin hydrogels and improves eEPC migration in vitro. J Control Release 2012, 162:68-75.
9. Bolognese L., Carrabba N., Parodi G., et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004, 109:1121-1126.
10. Boodhwani M., Sodha N.R., Laham R.J., Sellke F.W. The future of therapeutic myocardial angiogenesis. Shock 2006, 26:332-341.
11. Crump M.P., Gong J.H., Loetscher P., et al. Solution structure and basis for functional activity of stromal cell-derived factor-1: Dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J 1997, 16:6996-7007.
12. Davis D.A., Singer K.E., De La Luz Sierra M., et al. Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation. Blood 2005, 105:4561-4568.
13. De La Luz Sierra M., Yang F., Narazaki M., et al. Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood 2004, 103:2452-2459.
14. Dealwis C., Fernandez E.J., Thompson D.A., et al. Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 "fusin" coreceptor. Proc Natl Acad Sci U S A 1998, 95:6941-6946.
15. Ejiri M., Fujita M., Sakai O., et al. Development of collateral circulation after acute myocardial infarction: Its role in preserving left ventricular function. J Cardiol 1990, 20:31-37.
16. Elmadbouh I., Haider H.K., Jiang S., et al. Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol 2007, 42:792-803.
17. Fiser A., Do R.K., Sali A. Modeling of loops in protein structures. Protein Sci 2000, 9:1753-1773.
18. Garot P., Pascal O., Simon M., et al. Impact of microvascular integrity and local viability on left ventricular remodelling after reperfused acute myocardial infarction. Heart 2003, 89:393-397.
19. Ghadge S.K., Mühlstedt S., Ozcelik C., Bader M. SDF-1α as a therapeutic stem cell homing factor in myocardial infarction. Pharmacol Ther 2011, 129:97-108.
20. Hiesinger W., Perez-Aguilar J.M., Atluri P., et al. Computational protein design to reengineer stromal cell-derived factor-1α generates an effective and translatable angiogenic polypeptide analog. Circulation 2011, 124:S18-S26.
21. Jayasankar V., Woo Y.J., Bish L.T., et al. Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure. Circulation 2003, 108(Suppl 1):II230-II236.
22. Jayasankar V., Woo Y.J., Pirolli T.J., et al. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure. J Card Surg 2005, 20:93-9101.
23. Kai H., Ikeda H., Yasukawa H., et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998, 32:368-372.
24. Kolakowski S., Berry M.F., Atluri P., et al. Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy. J Card Surg 2006, 21:559-564.
25. Luo J., Luo Z., Zhou N., et al. Attachment of C-terminus of SDF-1 enhances the biological activity of its N-terminal peptide. Biochem Biophys Res Commun 1999, 264:42-47.
26. McQuibban G.A., Butler G.S., Gong J.H., et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 2001, 276:43503-43508.
27. Möhle R., Bautz F., Rafii S., et al. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998, 91:4523-4530.
28. Ortiz-Pérez J.T., Lee D.C., Meyers S.N., et al. Determinants of myocardial salvage during acute myocardial infarction: Evaluation with a combined angiographic and CMR myocardial salvage index. J JAAC Cardiovasc Imaging 2010, 3:491-500.
29. Peng S.B., Peek V., Zhai Y., et al. Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1alpha/CXCR4-mediated migration of epitheloid carcinoma cells. Mol Cancer Res 2005, 3:227-236.
30. Petit I., Szyper-Kravitz M., Nagler A., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002, 3:687-694.
31. Pillarisetti K., Gupta S.K. Cloning and relative expression analysis of rat stromal cell derived factor-1 (SDF-1)1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction. Inflammation 2001, 25:293-300.
32. Prokoph S., Chavakis E., Levental K.R., et al. Sustained delivery of SDF-1α from heparin-based hydrogels to attract circulating pro-angiogenic cells. Biomaterials 2012, 33:4792-4800.
33. Renault M.A., Losordo D.W. Therapeutic myocardial angiogenesis. Microvasc Res 2007, 74:159-171.
34. Rigo F., Varga Z., Di Pede F., et al. Early assessment of coronary flow reserve by transthoracic Doppler echocardiography predicts late remodeling in reperfused anterior myocardial infarction. J Am Soc Echocardiogr 2004, 17:750-755.
35. Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease. Nature 2008, 451:937-942.
36. Segers V.F., Tokunou T., Higgins L.J., et al. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation 2007, 116:1683-1692.
37. Tang J., Wang J., Song H., et al. Adenovirus-mediated stromal cell-derived factor-1 alpha gene transfer improves cardiac structure and function after experimental myocardial infarction through angiogenic and antifibrotic actions. Mol Biol Rep 2010, 37:1957-1969.
38. Tang J., Wang J., Yang J., Kong X. Adenovirus-mediated stromal cell-derived- factor-1alpha gene transfer induces cardiac preservation after infarction via angiogenesis of CD133+ stem cells and anti-apoptosis. Interact Cardiovasc Thorac Surg 2008, 7:767-770.
39. Tang J., Wang J., Yang J., et al. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg 2009, 36:644-650.
40. Tang Y.L., Zhu W., Cheng M., et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 2009, 104:1209-1216.
41. Woo Y.J., Grand T.J., Berry M.F., et al. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. J Thorac Cardiovasc Surg 2005, 130:321-329.
42. Yamaguchi J., Kusano K.F., Masuo O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328.
43. Zaruba M.M., Theiss H.D., Vallaster M., et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell 2009, 4:313-323.
44. Zeng H., Li L., Chen J.X. Overexpression of angiopoietin-1 increases CD133+/c-kit+ cells and reduces myocardial apoptosis in db/db mouse infarcted hearts. PLoS ONE 2012, 7:e35905.
45. Zhao T., Zhang D., Millard R.W., et al. Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling. Am J Physiol Heart Circ Physiol 2009, 296:H976-H986.